ACLA In The News

  • Roll Call Commentary: In Diagnostic Innovation, Something Incredible Is Waiting to Be Known

    September 15, 2014
    Astronomer, scientist and writer Carl Sagan is thought to have said, “Somewhere, something incredible is waiting to be known.” I know what that statement means because I live and breathe the reality of discovery every day, as do my colleagues practicing at nonprofit clinical laboratories in academic medical centers across the nation. We are engaged in scientific innovation that has improved the lives of countless patients. Congress hasContinue Reading »...
  • Senators Ask CMS to Put Changes To Doc Fee Codes in Proposed Rule

    June 24, 2014
    Bloomberg BNA June 23 — Twelve senators have asked the Centers for Medicare & Medicaid Services to place information on modifications of physician codes in the upcoming proposed Medicare Part B fee schedule, rather than just in the final rule. Placing “the results of CMS’s analysis and the rationale for any payment modifications” just in the final rule “limits the ability of providers to review the rationale and variousContinue Reading »...
  • Bloomberg BNA: Lab Industry Optimistic About New System Based on Private Pay Report Submissions

    April 25, 2014
    An upcoming market-based system for pricing services performed by clinical laboratories is a “better alternative” for the industry than the current Medicare payment system, the president of the American Clinical Laboratory Association said April 23. Although many questions remain to be answered, the system to align Medicare payment rates with the private sector will allow labs to avoid “multiple threats” to reimbursements, ACLA PresidentContinue Reading »...
  • ‘No rationale’ for Tricare’s refusal to cover genetic tests

    March 11, 2014
    A change in medical classifications last year has left clinical laboratories across the U.S. carrying a $10 million tab for Tricare. Tricare beneficiaries have not been billed for certain physician-ordered tests they have received at clinical laboratories since Jan. 1, 2013 — but Tricare also has not paid for them. At the heart of the standoff are genetic tests developed by laboratories that areContinue Reading »...
  • Innovation must be part of the cost evaluation of healthcare

    March 11, 2014
    Arguments can be made on both sides about access and quality, when comparing our healthcare system to the rest of the industrialized world. But, few would dispute that American healthcare is the most innovative in the world. In fact, the creativity and expertise of American manufacturers, doctors, hospitals and Academic Medical Centers, laboratories, drug companies, health IT companies, and other participants set the standardContinue Reading »...
  • Lab testing a Medicare cost saver

    February 18, 2014
    Sen. Ron Wyden (D-Ore.), the new chairman of the Senate Finance Committee and a longtime champion of improving chronic disease care, is in a position to play an important role in reforming Medicare. Wyden has long advocated a Medicare program that would feature improved care coordination for chronic disease, which would save lives and improve the quality of life for beneficiaries, while saving MedicareContinue Reading »...
  • DHA operations chief vows some relief from surprise lab fees

    February 06, 2014
    Army Maj. Gen. Richard W. Thomas, newly assigned as chief medical officer and director of healthcare operations for the new Defense Health Agency (DHA), acknowledges that some Tricare patients and their civilian physicians face lab fee challenges that the DHA needs to address. A year ago Tricare, the military’s health insurance program, quietly stopped reimbursing civilian laboratories for more than 100 genetic or laboratory-developedContinue Reading »...
  • Pay cuts could wipe out labs, hurt nursing homes

    February 05, 2014
    When it comes to worries about how Medicare doctors will be paid, nursing home operators have thought they should stand at the front of a long and anxious line. Truth be told, they have some stiff competition for the “most nervous” title. That might go to the clinical lab folks. Although many provider groups are worried about which will have to sacrifice the mostContinue Reading »...
  • Tricare users will soon pay more for some medical tests, maintenance medications only available through mail

    January 13, 2014
    Tricare beneficiaries will soon pay more for some diagnostic genetic tests ordered by their civilian physicians – including procedures used to detect cystic fibrosis or determine cancer treatments – if the Defense Health Agency deems them to be medically unnecessary. Stars and Stripes is reporting Tricare stopped reimbursing clinical laboratories in January 2013 for more than 100 different genetic or molecular pathology tests. The laboratoriesContinue Reading »...
  • MILITARY UPDATE: Some lab fees soon will be billed to Tricare patients

    January 11, 2014
    TRICARE beneficiaries soon will have to pay out of pocket for certain diagnostic genetic tests their civilian physicians order but the Defense Health Agency doesn’t view as appropriate or medically necessary. In January 2013, without notice to beneficiaries or to health care providers, TRICARE stopped reimbursing clinical laboratories for more than 100 different genetic or “molecular pathology” tests. Beneficiaries haven’t complained yet because theContinue Reading »...
1 2 3 4 5 6